PPP1R3A and type 2 diabetes mellitus: Rg1 exerts anti-T2D effects; improves IR, hepatic function, and blood lipid levels in T2D rats [8,9]; and promotes glucose consumption (GC) by insulin-resistant hepatic [10–12] and muscle cells [13].